CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 15 enrolled
Drug / intervention
Testosterone replacement +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01873989
NCT01873989Phase 2Completed
CompareCT.gov

Testosterone Replacement for Male Opioid Agonist Maintained Patients

Yale University·interventional·Posted Jun 10, 2013·Updated Jun 12, 2017

In Brief

A Phase 2 clinical trial evaluating Testosterone replacement and Waitlist control for Chronic Pain and 2 related conditions. Completed, enrolled 15 participants across 1 site.

Detailed Summary

This study is designed to develop an effective treatment intervention for chronic pain, symptomatic hypogonadism, and opioid addiction

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Pain, Opioid Addiction, Symptomatic Hypogonadism
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJun 10, 2013
Enrollment StartApr 1, 2012
Primary CompletionJan 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 13.1 years ago

Interventions

Testosterone replacementdrug

Waitlist controlother